Home

Latest News

Mount Sinai in New York City Offers Gallium-68 Imaging for Carcinoid and Neuroendocrince Cancer Patients

When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. Now in clinical studies in the United States, the Gallium-68 scan enables physicians to diagnose, stage, and monitor response to treatments in carcinoid and neuroendocrine cancer patients. Read more

Spotlight on Guest Bloggers for CCF

The Carcinoid Cancer Foundation is pleased to announce that we are going to feature guest contributors to our blog during 2015. Intelligent Patients – Just What the Doctor Didn’t Order by Ronny Allan, a carcinoid cancer patient from the UK, is our first guest blog post. Read the post here.

New Mobile Platform to Help Carcinoid Cancer and NET Patients Take Control of Their Rare Diseases

The Carcinoid Cancer Foundation and the patient intelligence health solution provider Self Care Catalysts have announced a new partnership to provide carcinoid and neuroendocrine tumor (NET) patients with a new mobile patient support tool. The Carcinoid NETs app will be made available free of charge early in 2015, accessible online through a desktop computer and as a mobile app which can be downloaded from the Google Play and Apple App Stores.  Read more

CCF Awards Grant to Stanford University

The Carcinoid Cancer Foundation has awarded a grant of more than $65,000.00 to Stanford University in California to expand access to its Gallium-68 (Ga-68) DOTA-TATE PET/CT program for carcinoid and neuroendocrine tumor (NET) patients with somatostatin receptor positive tumors. Read more

Surgery and Treatment Options for NET Cancers

What are the surgical and treatment options for carcinoid and neuroendocrine tumor patients?  For patients with tumors that have spread to the liver which therapies should be used to improve quality and quantity of life? How do patients benefit from clinical trials? There is an explosion of technologies coming not only in the diagnostics but also in the treatments of these rare cancers. View the video below: